Chantal Mustoe

Chantal Mustoe is a Research Fellow at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, United Kingdom. Her work focuses on pharmaceutical process engineering with emphasis on crystallization science and computational optimization to advance sustainable drug manufacturing.

Her research expertise spans crystallization processes, adaptive optimization techniques, and sustainable medicines development. She specializes in applying Bayesian optimization to batch cooling crystallization, solvent selection, and quality-by-design frameworks. Her fingerprint analysis reveals strong contributions to Pharmacology, Toxicology and Pharmaceutical Science (100% for Crystallization and Mefenamic Acid research) and Engineering disciplines (75% for Development, 71% for Optimization).

Recent publications demonstrate integration of digital design methodologies with pharmaceutical manufacturing. The 2025 article establishes workflows for crystallization/isolation using design of experiments and control strategies, while the 2024 comparative study examines kinetic regimes in crystallization optimization. Both works emphasize environmental sustainability and product quality enhancement through data-driven engineering approaches.

Dr. Mustoe actively collaborates across interdisciplinary networks, contributing to UN Sustainable Development Goals (particularly Goal 12 on Responsible Consumption). Her co-authorship on projects involving 30+ researchers highlights strong institutional partnerships in pharmaceutical innovation.